Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients
Approximately half of breast cancer patients with stage I–III disease will suffer metastatic disease despite resection with tumour-free margins. In 30–40% of these patients, individual carcinoma cells can already be detected at the time of primary therapy in cytological bone marrow preparations usin...
Tallennettuna:
| Julkaisussa: | Breast Cancer Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2001
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138689/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11597315/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr308 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|